Hanson & Doremus Investment Management Zimmer Biomet Holdings, Inc. Transaction History

Hanson & Doremus Investment Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 25, 2024	SELL	$102.72 - $121.7 $8,731 - $10,344	-85 Reduced 94.44%	5 $0
Q2 2023 Jul 18, 2023	BUY	$126.43 - $145.6 $11,378 - $13,104	90 New	90 $13,000
Q4 2022 Jan 18, 2023	SELL	$104.7 - $128.4 $12,564 - $15,408	-120 Reduced 78.43%	33 $4,000
Q2 2019 Jul 18, 2019	SELL	$108.87 - $125.09 $12,846 - $14,760	-118 Reduced 43.54%	153 $18,000
Q3 2017 Oct 26, 2017	BUY	$106.92 - $117.79 $28,975 - $31,921	271	271 $0

1,081

179M

301K

Ticker ZBH
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 209,820,000
Market Cap $23.2B
Description
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...

Get notified when there are updates to the investment portfolio of Hanson & Doremus Investment Management, based on Form 13F filings with the SEC.

Stay updated on Hanson & Doremus Investment Management with notifications on news.